Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXE6VD
|
||||
| Drug Name |
N-((S)-3-cycloheptyl-1-((4S,7R)-7-methyl-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylamino)-1-oxopropan-2-yl)furan-2-carboxamide
|
||||
| Synonyms |
CHEMBL1807648
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H36N4O6S
|
||||
| Canonical SMILES |
C[C@@H]1CC[C@H](NC(=O)[C@H](CC2CCCCCC2)NC(=O)c3occc3)C(=O)CN1S(=O)(=O)c4ccccn4
|
||||
| InChI |
InChI=1S/C27H36N4O6S/c1-19-13-14-21(23(32)18-31(19)38(35,36)25-12-6-7-15-28-25)29-26(33)22(17-20-9-4-2-3-5-10-20)30-27(34)24-11-8-16-37-24/h6-8,11-12,15-16,19-22H,2-5,9-10,13-14,17-18H2,1H3,(H,29,33)(H,30,34)/t19-,21+,22+/m1/s1
|
||||
| InChIKey |
ZXZJJTNSWFRIRU-HJNYFJLDSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.